⌘K

Home/Filings/4/0001144204-13-065626

4//SEC Filing

ENDOCYTE INC 4

Accession 0001144204-13-065626

CIK 0001235007operating

View on SEC.gov Company Profile

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 5:24 PM ET

Size

9.2 KB

Accession

0001144204-13-065626

Insider Transaction Report

Form 4

Period: 2013-12-02

ENDOCYTE INCECYT

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock
2013-12-04$1.91/sh+3,000$5,730→ 29,154 total
Exercise/Conversion
Stock option (right to buy)
2013-12-04−3,000→ 21,267 total
Exercise: $1.91Exp: 2016-02-17→ Common Stock (3,000 underlying)
Sale
Common Stock
2013-12-02$12.00/sh−3,000$36,000→ 26,154 total

Holdings

Common Stock
75,332

Footnotes (3)

[F1]The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
[F2]The reported securities are owned directly by P. Ron Ellis and Margaret Heard Ellis, JTWROS.
[F3]The option is fully vested and immediately exercisable.

Documents

1 file

4
v362232_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001235007

Filing Metadata

Form type: 4
Filed: Dec 3, 7:00 PM ET
Accepted: Dec 4, 5:24 PM ET
Size: 9.2 KB

View on SEC.gov